Pfizer begins work on vaccine against Omicron strain
Albert Burla, CEO of Pfizer, said the company has already begun work on a vaccine specifically targeting the new Omicron coronavirus strain. AFP reports this.
A new vaccine, developed specifically against the new strain, may be needed if the existing vaccine proves ineffective.
Burla said he did not think the vaccines did not protect , but if trials show that existing drugs “ protect less, '' then that would mean a new vaccine needs to be developed.
The Pfizer CEO compared the current situation with the beginning of the year, when Pfizer and BioNTech developed a vaccine for 95 days, because there were fears that the vaccines available at that time would not work against the Delta strain.
Related Posts
About The Author
Elizabeth
Elizabeth Stone has been a reporter on the news desk since 2013. Before that she wrote about young adolescence and family dynamics for Styles and was the legal affairs correspondent for the Metro desk. Before joining The Quebec Telegram, Elizabeth Stone worked as a staff writer at the Village Voice and a freelancer for Newsday, The Wall Street Journal, GQ and Mirabella. To get in touch, contact me through my stone@qtelegram.com 1-800-268-7116